Literature DB >> 23886890

Molecular and functional alterations in a mouse cardiac model of Friedreich ataxia: activation of the integrated stress response, eIF2α phosphorylation, and the induction of downstream targets.

Michael Li-Hsuan Huang1, Sutharshani Sivagurunathan, Samantha Ting, Patric J Jansson, Christopher J D Austin, Matthew Kelly, Christopher Semsarian, Daohai Zhang, Des R Richardson.   

Abstract

Friedreich ataxia (FA) is a neurodegenerative and cardiodegenerative disease resulting from marked frataxin deficiency. The condition is characterized by ataxia with fatal cardiomyopathy, but the pathogenic mechanisms are unclear. We investigated the association between gene expression and progressive histopathological and functional changes using the muscle creatine kinase conditional frataxin knockout (KO) mouse; this mouse develops a severe cardiac phenotype that resembles that of FA patients. We examined KO mice from 3 weeks of age, when they are asymptomatic, to 10 weeks of age, when they die of the disease. Positive iron staining was identified in KO mice from 5 weeks of age, with markedly reduced cardiac function from 6 weeks. We identified an early and marked up-regulation of a gene cohort responsible for stress-induced amino acid biosynthesis and observed markedly increased phosphorylation of eukaryotic translation initiation factor 2α (p-eIF2α), an activator of the integrated stress response, in KO mice at 3 weeks of age, relative to wild-type mice. Importantly, the eIF2α-mediated integrated stress response has been previously implicated in heart failure via downstream processes such as autophagy and apoptosis. Indeed, expression of a panel of autophagy and apoptosis markers was enhanced in KO mice. Thus, the pathogenesis of cardiomyopathy in FA correlates with the early and persistent eIF2α phosphorylation, which precedes activation of autophagy and apoptosis.
Copyright © 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23886890     DOI: 10.1016/j.ajpath.2013.05.032

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

Review 1.  Untangling autophagy measurements: all fluxed up.

Authors:  Roberta A Gottlieb; Allen M Andres; Jon Sin; David P J Taylor
Journal:  Circ Res       Date:  2015-01-30       Impact factor: 17.367

2.  Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis.

Authors:  Tslil Ast; Joshua D Meisel; Shachin Patra; Hong Wang; Robert M H Grange; Sharon H Kim; Sarah E Calvo; Lauren L Orefice; Fumiaki Nagashima; Fumito Ichinose; Warren M Zapol; Gary Ruvkun; David P Barondeau; Vamsi K Mootha
Journal:  Cell       Date:  2019-04-25       Impact factor: 41.582

Review 3.  Regulation and function of elF2B in neurological and metabolic disorders.

Authors:  Filipe M Hanson; Rachel E Hodgson; Madalena I Ribeiro de Oliveira; K Elizabeth Allen; Susan Gerarda Campbell
Journal:  Biosci Rep       Date:  2022-06-30       Impact factor: 3.976

4.  Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia.

Authors:  Morgane Perdomini; Brahim Belbellaa; Laurent Monassier; Laurence Reutenauer; Nadia Messaddeq; Nathalie Cartier; Ronald G Crystal; Patrick Aubourg; Hélène Puccio
Journal:  Nat Med       Date:  2014-04-06       Impact factor: 53.440

Review 5.  Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia.

Authors:  A Anzovino; D J R Lane; M L-H Huang; D R Richardson
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

6.  An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse models.

Authors:  Catherine Gérard; Xiao Xiao; Mohammed Filali; Zoé Coulombe; Marie Arsenault; Jacques Couet; Juan Li; Marie-Claude Drolet; Pierre Chapdelaine; Amina Chikh; Jacques P Tremblay
Journal:  Mol Ther Methods Clin Dev       Date:  2014-10-08       Impact factor: 6.698

7.  Implication of KRT16, FAM129A and HKDC1 genes as ATF4 regulated components of the integrated stress response.

Authors:  Alexandra G Evstafieva; Irina E Kovaleva; Maria S Shoshinova; Andrei V Budanov; Peter M Chumakov
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

8.  Quantitative proteomic analysis identifies targets and pathways of a 2-aminobenzamide HDAC inhibitor in Friedreich's ataxia patient iPSC-derived neural stem cells.

Authors:  Bing Shan; Chunping Xu; Yaoyang Zhang; Tao Xu; Joel M Gottesfeld; John R Yates
Journal:  J Proteome Res       Date:  2014-06-26       Impact factor: 4.466

9.  Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy.

Authors:  Shota Sasagawa; Yuhei Nishimura; Shiko Okabe; Soichiro Murakami; Yoshifumi Ashikawa; Mizuki Yuge; Koki Kawaguchi; Reiko Kawase; Ryuji Okamoto; Masaaki Ito; Toshio Tanaka
Journal:  Front Pharmacol       Date:  2016-06-14       Impact factor: 5.810

10.  CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells.

Authors:  Stefan Reber; Jonas Mechtersheimer; Sofia Nasif; Julio Aguila Benitez; Martino Colombo; Michal Domanski; Daniel Jutzi; Eva Hedlund; Marc-David Ruepp
Journal:  Mol Biol Cell       Date:  2017-11-22       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.